Expression of potential therapeutic targets COX-2 and c-kit in breast cancer: Assessment and correlations using tissue microarrays

被引：0
|
作者：
Gown, AM
Yaziji, H
Hwang, HC
Barry, TS
Nielsen, TO
Hsu, FD
Bacchi, CE
机构：
[1] PhenoPath Labs, Seattle, WA USA
[2] IRIS, Seattle, WA USA
[3] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[4] Univ Estadual Paulista Julio Mesquita Filho, Botucatu, SP, Brazil
来源：
LABORATORY INVESTIGATION | 2003年 / 83卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
126
引用
收藏
页码：31A / 31A
页数：1
相关论文
共 50 条
  • [31] Expression of c-kit proto-oncogene product in breast cancer tissues
    Aydan Eroğlu
    Aliye Sari
    [J]. Medical Oncology, 2007, 24 : 169 - 174
  • [32] COX-2 expression in gastric cancer and its relationship with angiogenesis using tissue microarray
    Xiao-Yun Mao
    [J]. World Journal of Gastroenterology, 2007, (25) : 3466 - 3471
  • [33] COX-2 expression in gastric cancer and its relationship with angiogenesis using tissue microarray
    Mao, Xiao-Yun
    Wang, Xiao-Ge
    Lv, Xiao-Jun
    Xu, Lei
    Han, Cheng-Bo
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (25) : 3466 - 3471
  • [34] Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
    Babaei, Maryam Abbaspour
    Kamalidehghan, Behnam
    Saleem, Mohammad
    Huri, Hasniza Zaman
    Ahmadipour, Fatemeh
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2443 - 2459
  • [35] C-kit mRNA expression in pancreatic adenocarcinoma and matched stromal tissue: Prognostic and therapeutic implications
    Grimminger, Peter Philipp
    Stephens, Craig
    Waldschmidt, Dirk
    Astrow, Stephanie H.
    Steffen, Hans-Michael
    Hsiang, Jack
    Zeger, Gary
    Hoelscher, Arnulf H.
    Maus, Marlin K. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] Characterization of c-kit expression in small cell lung cancer:: Prognostic and therapeutic implications
    Micke, P
    Basrai, M
    Faldum, A
    Bittinger, F
    Rönnstrand, L
    Blaukat, A
    Beeh, KM
    Oesch, F
    Fischer, B
    Buhl, R
    Hengstler, JG
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (01) : 188 - 194
  • [37] Potential use of COX-2–aromatase inhibitor combinations in breast cancer
    N J Bundred
    N L P Barnes
    [J]. British Journal of Cancer, 2005, 93 : S10 - S15
  • [38] Evaluation of the therapeutic potential of masitinib and expression of its specific targets c-Kit, PDGFR-α, PDGFR-β, and Lyn in canine prostate cancer cell lines
    Klose, Katharina
    Packeiser, Eva-Maria
    Granados-Soler, Jose-Luis
    Hewicker-Trautwein, Marion
    Escobar, Hugo Murua
    Nolte, Ingo
    [J]. VETERINARY AND COMPARATIVE ONCOLOGY, 2022, 20 (03) : 641 - 652
  • [39] A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer
    Tsutsui, S.
    Yasuda, K.
    Suzuki, K.
    Takeuchi, H.
    Nishizaki, T.
    Higashi, H.
    Era, S.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (12) : 1874 - 1878
  • [40] c-kit: identification of coregulated genes in breast cancer patients by gene expression analysis
    不详
    [J]. EJC SUPPLEMENTS, 2006, 4 (02): : 143 - 143
12345